LEUKEMIA MYELOMONOCYTIC CHRONIC
Clinical trials for LEUKEMIA MYELOMONOCYTIC CHRONIC explained in plain language.
Never miss a new study
Get alerted when new LEUKEMIA MYELOMONOCYTIC CHRONIC trials appear
Sign up with your email to follow new studies for LEUKEMIA MYELOMONOCYTIC CHRONIC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Drug dasatinib tested for rare blood cancers
Disease control CompletedThis study tested the drug dasatinib in 68 adults with several types of blood and bone marrow disorders, including certain leukemias, myelofibrosis, and mastocytosis. The goal was to see if dasatinib could help control the disease and to check its safety. Participants took dasati…
Matched conditions: LEUKEMIA MYELOMONOCYTIC CHRONIC
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC
-
New combo therapy shows promise for tough blood cancers
Disease control CompletedThis study tested whether adding pevonedistat to the standard drug azacitidine helps people with higher-risk myelodysplastic syndromes, chronic myelomonocytic leukemia, or low-blast acute myeloid leukemia live longer without their disease getting worse. About 454 adults took part…
Matched conditions: LEUKEMIA MYELOMONOCYTIC CHRONIC
Phase: PHASE3 • Sponsor: Takeda • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC